Trevi Therapeutics
TRVI
TRVI
40 hedge funds and large institutions have $70.5M invested in Trevi Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $79.6M → $70.5M (-$9.13M)
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.78M | |
| 2 | +$6.52M | |
| 3 | +$6.27M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.02M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.27M |
Top Sellers
| 1 | -$6.28M | |
| 2 | -$487K | |
| 3 | -$336K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$70.4K |
| 5 |
Millennium Management
New York
|
-$40.7K |